Review




Structured Review

Rotem Industries rotem based transfusion algorithm
Rotem Based Transfusion Algorithm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotem+based+transfusion+algorithm/algorithms+guided+rotem+transfusion/pmc12597362-270-196-196
Average 86 stars, based on 1 article reviews
rotem based transfusion algorithm - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

Control:

Article Title: Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis
Article Snippet: Hartmann and colleagues 35 (2019) (Germany) , Retrospective cohort , 372 , Patients undergoing deceased donor LT , Factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates. FC was administered in 187 (50%) patients (range 1–22 g); PCC (CSL Behring) was administered in 70 (19%) patients (range 1000–7000 U) , Multivariate logistic regression used including administration of FC, PCC, RBC concentrates, platelet concentrates, infused and transfused volume as a surrogate of blood loss, tranexamic acid use, and MELD score , Standardised ROTEM-guided transfusion algorithm including factor concentrates and not plasma, with EXTEM, INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, done at: (1) baseline at the beginning of surgery; (2) anhepatic phase; (3) after reperfusion; (4) end of procedure; (5) at discretion of anaesthesiologist , Intraoperative cell salvage was used in all patients without cancer. Tranexamic acid administration was guided by a standardised algorithm, and was administered to 91 (24%) with evidence of hyperfibrinolysis. The most common dose was 2 g.. .. Nascimento and colleagues 36 (2020) (Brazil) , Mixed retrospective ( n =82) and prospective ( n =71) , 153 82 patients evaluated using a ROTEM-based transfusion algorithm, and 71 patients using conventional management , Adults undergoing OLT from 2014–7 ( n =71) and 2009–13 ( n =82) , Comparator: factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates ( n =82) Control: management using conventional coagulation tests ( n =71) FC or cryoprecipitate was administered in 55% of intervention vs 20% of control patients; PCC was administered in 33% of intervention vs 10% of control patients Guided by ROTEM: FC mean dose: 0.8 ( sd 1.8) g PCC mean dose: 1.4 ( sd 2.3) IU Guided by conventional laboratory tests: FC mean dose: 0.2 ( sd 0.9) g PCC mean dose: 0.2 ( sd 0.7) IU , None Significant baseline differences in the ROTEM group compared with conventional management group. Patients in the ROTEM group were more likely to be undergoing re-transplantation owing to thrombosis of hepatic arteries or veins, or owing to graft rejection (10% vs 1%); the surgical time was also longer in the ROTEM group. , ROTEM-based transfusion algorithm with INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, or conventional coagulation tests with EXTEM, done at: (1) before skin incision; (2) anhepatic phase during vena cava anastomosis; (3) neohepatic phase at bile duct anastomosis; (4) 10 min after transfusion interventions , All patients underwent a piggyback surgical technique. Cell salvage used in all patients aside from HCC or infection. Patients received EACA 50 mg kg −1 if EXTEM ML60 >15% and APTEM ML60 <15%.. ..

Coagulation:

Article Title: Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis
Article Snippet: Hartmann and colleagues 35 (2019) (Germany) , Retrospective cohort , 372 , Patients undergoing deceased donor LT , Factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates. FC was administered in 187 (50%) patients (range 1–22 g); PCC (CSL Behring) was administered in 70 (19%) patients (range 1000–7000 U) , Multivariate logistic regression used including administration of FC, PCC, RBC concentrates, platelet concentrates, infused and transfused volume as a surrogate of blood loss, tranexamic acid use, and MELD score , Standardised ROTEM-guided transfusion algorithm including factor concentrates and not plasma, with EXTEM, INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, done at: (1) baseline at the beginning of surgery; (2) anhepatic phase; (3) after reperfusion; (4) end of procedure; (5) at discretion of anaesthesiologist , Intraoperative cell salvage was used in all patients without cancer. Tranexamic acid administration was guided by a standardised algorithm, and was administered to 91 (24%) with evidence of hyperfibrinolysis. The most common dose was 2 g.. .. Nascimento and colleagues 36 (2020) (Brazil) , Mixed retrospective ( n =82) and prospective ( n =71) , 153 82 patients evaluated using a ROTEM-based transfusion algorithm, and 71 patients using conventional management , Adults undergoing OLT from 2014–7 ( n =71) and 2009–13 ( n =82) , Comparator: factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates ( n =82) Control: management using conventional coagulation tests ( n =71) FC or cryoprecipitate was administered in 55% of intervention vs 20% of control patients; PCC was administered in 33% of intervention vs 10% of control patients Guided by ROTEM: FC mean dose: 0.8 ( sd 1.8) g PCC mean dose: 1.4 ( sd 2.3) IU Guided by conventional laboratory tests: FC mean dose: 0.2 ( sd 0.9) g PCC mean dose: 0.2 ( sd 0.7) IU , None Significant baseline differences in the ROTEM group compared with conventional management group. Patients in the ROTEM group were more likely to be undergoing re-transplantation owing to thrombosis of hepatic arteries or veins, or owing to graft rejection (10% vs 1%); the surgical time was also longer in the ROTEM group. , ROTEM-based transfusion algorithm with INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, or conventional coagulation tests with EXTEM, done at: (1) before skin incision; (2) anhepatic phase during vena cava anastomosis; (3) neohepatic phase at bile duct anastomosis; (4) 10 min after transfusion interventions , All patients underwent a piggyback surgical technique. Cell salvage used in all patients aside from HCC or infection. Patients received EACA 50 mg kg −1 if EXTEM ML60 >15% and APTEM ML60 <15%.. ..

Periodic Counter-current Chromatography:

Article Title: Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis
Article Snippet: Hartmann and colleagues 35 (2019) (Germany) , Retrospective cohort , 372 , Patients undergoing deceased donor LT , Factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates. FC was administered in 187 (50%) patients (range 1–22 g); PCC (CSL Behring) was administered in 70 (19%) patients (range 1000–7000 U) , Multivariate logistic regression used including administration of FC, PCC, RBC concentrates, platelet concentrates, infused and transfused volume as a surrogate of blood loss, tranexamic acid use, and MELD score , Standardised ROTEM-guided transfusion algorithm including factor concentrates and not plasma, with EXTEM, INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, done at: (1) baseline at the beginning of surgery; (2) anhepatic phase; (3) after reperfusion; (4) end of procedure; (5) at discretion of anaesthesiologist , Intraoperative cell salvage was used in all patients without cancer. Tranexamic acid administration was guided by a standardised algorithm, and was administered to 91 (24%) with evidence of hyperfibrinolysis. The most common dose was 2 g.. .. Nascimento and colleagues 36 (2020) (Brazil) , Mixed retrospective ( n =82) and prospective ( n =71) , 153 82 patients evaluated using a ROTEM-based transfusion algorithm, and 71 patients using conventional management , Adults undergoing OLT from 2014–7 ( n =71) and 2009–13 ( n =82) , Comparator: factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates ( n =82) Control: management using conventional coagulation tests ( n =71) FC or cryoprecipitate was administered in 55% of intervention vs 20% of control patients; PCC was administered in 33% of intervention vs 10% of control patients Guided by ROTEM: FC mean dose: 0.8 ( sd 1.8) g PCC mean dose: 1.4 ( sd 2.3) IU Guided by conventional laboratory tests: FC mean dose: 0.2 ( sd 0.9) g PCC mean dose: 0.2 ( sd 0.7) IU , None Significant baseline differences in the ROTEM group compared with conventional management group. Patients in the ROTEM group were more likely to be undergoing re-transplantation owing to thrombosis of hepatic arteries or veins, or owing to graft rejection (10% vs 1%); the surgical time was also longer in the ROTEM group. , ROTEM-based transfusion algorithm with INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, or conventional coagulation tests with EXTEM, done at: (1) before skin incision; (2) anhepatic phase during vena cava anastomosis; (3) neohepatic phase at bile duct anastomosis; (4) 10 min after transfusion interventions , All patients underwent a piggyback surgical technique. Cell salvage used in all patients aside from HCC or infection. Patients received EACA 50 mg kg −1 if EXTEM ML60 >15% and APTEM ML60 <15%.. ..

FIBTEM Assay:

Article Title: Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis
Article Snippet: Hartmann and colleagues 35 (2019) (Germany) , Retrospective cohort , 372 , Patients undergoing deceased donor LT , Factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates. FC was administered in 187 (50%) patients (range 1–22 g); PCC (CSL Behring) was administered in 70 (19%) patients (range 1000–7000 U) , Multivariate logistic regression used including administration of FC, PCC, RBC concentrates, platelet concentrates, infused and transfused volume as a surrogate of blood loss, tranexamic acid use, and MELD score , Standardised ROTEM-guided transfusion algorithm including factor concentrates and not plasma, with EXTEM, INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, done at: (1) baseline at the beginning of surgery; (2) anhepatic phase; (3) after reperfusion; (4) end of procedure; (5) at discretion of anaesthesiologist , Intraoperative cell salvage was used in all patients without cancer. Tranexamic acid administration was guided by a standardised algorithm, and was administered to 91 (24%) with evidence of hyperfibrinolysis. The most common dose was 2 g.. .. Nascimento and colleagues 36 (2020) (Brazil) , Mixed retrospective ( n =82) and prospective ( n =71) , 153 82 patients evaluated using a ROTEM-based transfusion algorithm, and 71 patients using conventional management , Adults undergoing OLT from 2014–7 ( n =71) and 2009–13 ( n =82) , Comparator: factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates ( n =82) Control: management using conventional coagulation tests ( n =71) FC or cryoprecipitate was administered in 55% of intervention vs 20% of control patients; PCC was administered in 33% of intervention vs 10% of control patients Guided by ROTEM: FC mean dose: 0.8 ( sd 1.8) g PCC mean dose: 1.4 ( sd 2.3) IU Guided by conventional laboratory tests: FC mean dose: 0.2 ( sd 0.9) g PCC mean dose: 0.2 ( sd 0.7) IU , None Significant baseline differences in the ROTEM group compared with conventional management group. Patients in the ROTEM group were more likely to be undergoing re-transplantation owing to thrombosis of hepatic arteries or veins, or owing to graft rejection (10% vs 1%); the surgical time was also longer in the ROTEM group. , ROTEM-based transfusion algorithm with INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, or conventional coagulation tests with EXTEM, done at: (1) before skin incision; (2) anhepatic phase during vena cava anastomosis; (3) neohepatic phase at bile duct anastomosis; (4) 10 min after transfusion interventions , All patients underwent a piggyback surgical technique. Cell salvage used in all patients aside from HCC or infection. Patients received EACA 50 mg kg −1 if EXTEM ML60 >15% and APTEM ML60 <15%.. ..

Infection:

Article Title: Use of prothrombin complex concentrates in liver transplantation: a systematic review and meta-analysis
Article Snippet: Hartmann and colleagues 35 (2019) (Germany) , Retrospective cohort , 372 , Patients undergoing deceased donor LT , Factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates. FC was administered in 187 (50%) patients (range 1–22 g); PCC (CSL Behring) was administered in 70 (19%) patients (range 1000–7000 U) , Multivariate logistic regression used including administration of FC, PCC, RBC concentrates, platelet concentrates, infused and transfused volume as a surrogate of blood loss, tranexamic acid use, and MELD score , Standardised ROTEM-guided transfusion algorithm including factor concentrates and not plasma, with EXTEM, INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, done at: (1) baseline at the beginning of surgery; (2) anhepatic phase; (3) after reperfusion; (4) end of procedure; (5) at discretion of anaesthesiologist , Intraoperative cell salvage was used in all patients without cancer. Tranexamic acid administration was guided by a standardised algorithm, and was administered to 91 (24%) with evidence of hyperfibrinolysis. The most common dose was 2 g.. .. Nascimento and colleagues 36 (2020) (Brazil) , Mixed retrospective ( n =82) and prospective ( n =71) , 153 82 patients evaluated using a ROTEM-based transfusion algorithm, and 71 patients using conventional management , Adults undergoing OLT from 2014–7 ( n =71) and 2009–13 ( n =82) , Comparator: factor concentrate eligible group consistent of patients managed using a ROTEM-based algorithm that included factor concentrates ( n =82) Control: management using conventional coagulation tests ( n =71) FC or cryoprecipitate was administered in 55% of intervention vs 20% of control patients; PCC was administered in 33% of intervention vs 10% of control patients Guided by ROTEM: FC mean dose: 0.8 ( sd 1.8) g PCC mean dose: 1.4 ( sd 2.3) IU Guided by conventional laboratory tests: FC mean dose: 0.2 ( sd 0.9) g PCC mean dose: 0.2 ( sd 0.7) IU , None Significant baseline differences in the ROTEM group compared with conventional management group. Patients in the ROTEM group were more likely to be undergoing re-transplantation owing to thrombosis of hepatic arteries or veins, or owing to graft rejection (10% vs 1%); the surgical time was also longer in the ROTEM group. , ROTEM-based transfusion algorithm with INTEM, FIBTEM, and APTEM (for fibrinolysis detection) available, or conventional coagulation tests with EXTEM, done at: (1) before skin incision; (2) anhepatic phase during vena cava anastomosis; (3) neohepatic phase at bile duct anastomosis; (4) 10 min after transfusion interventions , All patients underwent a piggyback surgical technique. Cell salvage used in all patients aside from HCC or infection. Patients received EACA 50 mg kg −1 if EXTEM ML60 >15% and APTEM ML60 <15%.. ..



Similar Products

86
Rotem Industries rotem based transfusion algorithm
Rotem Based Transfusion Algorithm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotem+based+transfusion+algorithm/algorithms+guided+rotem+transfusion/pmc12597362-270-196-196
Average 86 stars, based on 1 article reviews
rotem based transfusion algorithm - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
Rotem Industries rotem® based transfusion algorithm
Guidance for pediatric fibrinogen replacement therapy from international guidelines.
Rotem® Based Transfusion Algorithm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotem+based+transfusion+algorithm/rotem+guided+transfusion/pmc08097134-246-33-31
Average 90 stars, based on 1 article reviews
rotem® based transfusion algorithm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Rotem Industries rotem-based transfusion algorithm
Guidance for pediatric fibrinogen replacement therapy from international guidelines.
Rotem Based Transfusion Algorithm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotem+based+transfusion+algorithm/rotem+guided+transfusion/pm27130495-75-12-12
Average 90 stars, based on 1 article reviews
rotem-based transfusion algorithm - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Rotem Industries mtp rotem based transfusion algorithm
Guidance for pediatric fibrinogen replacement therapy from international guidelines.
Mtp Rotem Based Transfusion Algorithm, supplied by Rotem Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotem+based+transfusion+algorithm/algorithms+guided+rotem+transfusion/10__1111_slash_tme__12183-1358-15-15
Average 86 stars, based on 1 article reviews
mtp rotem based transfusion algorithm - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Guidance for pediatric fibrinogen replacement therapy from international guidelines.

Journal: Frontiers in Pediatrics

Article Title: Pediatric Fibrinogen PART II—Overview of Indications for Fibrinogen Use in Critically Ill Children

doi: 10.3389/fped.2021.647680

Figure Lengend Snippet: Guidance for pediatric fibrinogen replacement therapy from international guidelines.

Article Snippet: The Fibrinogen Early in Severe Trauma Study (FEISTY) Junior is an Australian pediatric feasibility RCT comparing the use of early fibrinogen concentrate against cryoprecipitate in children with severe trauma using a ROTEM® based transfusion algorithm (FIBTEM A5 <10 mm as their threshold for intervention) ( ).

Techniques: Medications, Coagulation, Concentration Assay, Functional Assay, Clinical Proteomics